Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.

Read More